Intelligent Bio Solutions (INBS) Operating Leases (2023 - 2025)
Intelligent Bio Solutions' quarterly Operating Leases came in at $84659.0 in Q2 2025, up 4.1% year-on-year from $81324.0 in Q2 2024, and up 2185.61% quarter-over-quarter from $3704.0 in Q1 2025.
Intelligent Bio Solutions has reported Operating Leases for 3 years, with the latest figure at $84659.0 in Q2 2025.
- For the quarter ending Q2 2025, Operating Leases rose 4.1% year-over-year to $84659.0; the trailing twelve-month figure through Jun 2025 stood at $84659.0 (up 4.1% YoY), and the FY2025 full-year result was $84659.0, up 4.1% from the prior year.
- Operating Leases for Q2 2025 stood at $84659.0, up from $3704.0 in the prior quarter.
- The five-year high for Operating Leases was $511442.0 in Q3 2023, with the low at $3704.0 in Q1 2025.
- Average Operating Leases over 3 years is $191465.4, with a median of $84659.0 recorded in 2025.
- Peak annual rise in Operating Leases reached 4.1% in 2025, while the deepest fall reached 99.11% in 2025.
- Tracing INBS's Operating Leases over 3 years: stood at $228710.0 in 2023, then sank by 93.64% to $14535.0 in 2024, then surged by 482.45% to $84659.0 in 2025.
- The last three Operating Leases figures came in at $84659.0 (Q2 2025), $3704.0 (Q1 2025), and $14535.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 84,659.00 |
| Mar 31, 2025 | 3,704.00 |
| Dec 31, 2024 | 14,535.00 |
| Sep 30, 2024 | 28,111.00 |
| Jun 30, 2024 | 81,324.00 |
| Mar 31, 2024 | 414,539.00 |
| Dec 31, 2023 | 228,710.00 |
| Sep 30, 2023 | 511,442.00 |
| Jun 30, 2023 | 356,165.00 |